COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation
Status:
Enrolling by invitation
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether Fisetin, a senolytic drug, can assist in
preventing an increase in the disease's progression and alleviate complications of
coronavirus due to an excessive inflammatory reaction.